MTD Study of Vaccine BP-GMAX-CD1 Plus AP1903 to Treat Castrate Resistant Prostate Cancer

Clinical trial NCT00868595 · COMPLETED

Trial details

NCT number: NCT00868595
Sponsor: Bellicum Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Castrate Resistant Prostate Cancer (CRPC)

Start date: 2009-04-01
Primary completion: 2011-07-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.